Bosma R J, Krikken J A, Homan van der Heide J J, de Jong P E, Navis G J
Department of Medicine, Division of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Contrib Nephrol. 2006;151:184-202. doi: 10.1159/000095329.
Obesity is a risk factor for renal damage in native kidney disease and in renal transplant recipients. Obesity is associated with several renal risk factors such as hypertension and diabetes that may convey renal risk, but obesity is also associated with an unfavorable renal hemodynamic profile independent of these factors, and that may exert effects on renal damage as well. In animal models of obesity-associated renal damage, micro-puncture studies showed glomerular hypertension and hyperfiltration. In humans an elevated glomerular filtration rate has been demonstrated in several studies, sometimes associated with hyperperfusion as well, independent of blood pressure or the presence of diabetes. An elevated filtration fraction was found in several studies, consistent with glomerular hypertension. This renal hemodynamic profile resembles the hyperfiltration pattern in diabetes and is therefore assumed to be a pathogenetic factor in renal damage. Of note, the association between body mass index and renal hemodynamics is not limited to overt obesity or overweight, but is also present across the normal range, without a particular threshold. Multiple factors are assumed to contribute to these renal hemodynamic alterations, such as insulin resistance, the renin-angiotensin system and the tubulo-glomerular responses to increased proximal sodium reabsorption, and possibly also inappropriate activity of the sympathetic nervous system and increased leptin levels. Obesity has a high world-wide prevalence. On a population-basis, therefore, its contribution to long-term renal risk may be considerable, especially as it is usually clustered with risk factors like hypertension and insulin resistance. In short-term studies the renal hemodynamic alterations in obesity and the associated proteinuria were reversible by weight loss, and renin-angiotensin system-blockade, respectively. These interventions are therefore likely to have the potential to limit the renal risks of obesity.
肥胖是原发性肾病和肾移植受者发生肾损害的危险因素。肥胖与多种肾脏危险因素相关,如高血压和糖尿病,这些因素可能会带来肾脏风险,但肥胖还与独立于这些因素的不良肾脏血流动力学特征相关,这也可能对肾损害产生影响。在肥胖相关肾损害的动物模型中,微穿刺研究显示肾小球高血压和高滤过。在人类中,多项研究表明肾小球滤过率升高,有时还伴有高灌注,且与血压或糖尿病的存在无关。多项研究发现滤过分数升高,这与肾小球高血压一致。这种肾脏血流动力学特征类似于糖尿病中的高滤过模式,因此被认为是肾损害的致病因素。值得注意的是,体重指数与肾脏血流动力学之间的关联不仅限于明显肥胖或超重,在正常范围内也存在,且没有特定阈值。多种因素被认为促成了这些肾脏血流动力学改变,如胰岛素抵抗、肾素 - 血管紧张素系统以及肾小管 - 肾小球对近端钠重吸收增加的反应,交感神经系统活动异常以及瘦素水平升高也可能有影响。肥胖在全球范围内患病率很高。因此,从人群角度来看,其对长期肾脏风险的影响可能相当大,尤其是因为它通常与高血压和胰岛素抵抗等危险因素聚集在一起。在短期研究中,肥胖引起的肾脏血流动力学改变和相关蛋白尿分别通过减肥和肾素 - 血管紧张素系统阻断得以逆转。因此,这些干预措施可能有潜力限制肥胖带来的肾脏风险。